Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Zimmerman

Showing results (1-10 of 393) with videos related to

Pageof 40
Sort By:
Personality Disorders|July 5, 2022
Should the demonstration of improved patient outcome be necessary to overhaul diagnostic approaches?: Comment on Bach and Tracy (2022)Mark Zimmerman
Journal of Affective Disorders|June 23, 2021
Using Screening Scales for Bipolar Disorder in Epidemiologic Studies: Lessons Not Yet LearnedMark Zimmerman
The British Journal of Psychiatry : the Journal of Mental Science|June 3, 2016
The FDA's failure to address the lack of generalisability of antidepressant efficacy trials in product labellingMark Zimmerman
Personality Disorders|January 1, 2014
What is ironic about wanting empirical support to justify changes in diagnostic criteria? Commentary on "the ironic fate of the personality disorders in DSM-5"Mark Zimmerman
Psychotherapy and Psychosomatics|April 4, 2013
Reply: To PMID 22964496Mark Zimmerman
Essential Psychopharmacology|March 16, 2005
Can the findings of antidepressant efficacy trials be extrapolated to the general population of depressed patients? Interview by Dr. Frederic FlachMark Zimmerman
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|October 13, 2011
Broadening the concept of bipolar disorder: what should be done in the face of uncertainty?Mark Zimmerman
CNS Spectrums|January 13, 2017
Measures of the DSM-5 mixed-features specifier of major depressive disorderMark Zimmerman
The Journal of Clinical Psychiatry|August 25, 2022
Positive Predictive Value: A Clinician's Guide to Avoid Misinterpreting the Results of Screening TestsMark Zimmerman
Journal of Personality Disorders|April 21, 2015
Improving the Recognition of Borderline Personality Disorder in a Bipolar WorldMark Zimmerman
Pageof 40

Showing results (1-10 of 393) with videos related to

Sort By:
Pageof 40
Personality Disorders|July 5, 2022
Should the demonstration of improved patient outcome be necessary to overhaul diagnostic approaches?: Comment on Bach and Tracy (2022)Mark Zimmerman
Journal of Affective Disorders|June 23, 2021
Using Screening Scales for Bipolar Disorder in Epidemiologic Studies: Lessons Not Yet LearnedMark Zimmerman
The British Journal of Psychiatry : the Journal of Mental Science|June 3, 2016
The FDA's failure to address the lack of generalisability of antidepressant efficacy trials in product labellingMark Zimmerman
Personality Disorders|January 1, 2014
What is ironic about wanting empirical support to justify changes in diagnostic criteria? Commentary on "the ironic fate of the personality disorders in DSM-5"Mark Zimmerman
Psychotherapy and Psychosomatics|April 4, 2013
Reply: To PMID 22964496Mark Zimmerman
Essential Psychopharmacology|March 16, 2005
Can the findings of antidepressant efficacy trials be extrapolated to the general population of depressed patients? Interview by Dr. Frederic FlachMark Zimmerman
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|October 13, 2011
Broadening the concept of bipolar disorder: what should be done in the face of uncertainty?Mark Zimmerman
CNS Spectrums|January 13, 2017
Measures of the DSM-5 mixed-features specifier of major depressive disorderMark Zimmerman
The Journal of Clinical Psychiatry|August 25, 2022
Positive Predictive Value: A Clinician's Guide to Avoid Misinterpreting the Results of Screening TestsMark Zimmerman
Journal of Personality Disorders|April 21, 2015
Improving the Recognition of Borderline Personality Disorder in a Bipolar WorldMark Zimmerman
Pageof 40